| Archive Page Three |
a. The Prohibition Act of 1914
b. The FDA Narcotic Act
c. The Harrison Narcotic Act
d. The Opium Tax Act
a. Intrinsic activity
b. Agonistic ability
c. Antagonistic ability
d. Affinity
a. Active placebo
b. Saline solution
c. Prozac
d. Placebo
a. Competitive antagonism
b. Dose-response function
c. Synergism
d. Noncompetitive antagonism
a. pharmacology
b. pharmacodynamics
c. pharmacokinetics
d. neurological psychology
a. sodium-potassium pump
b. electrostatic pressure channels
c. postsynaptic receptors
d. voltage-gated channels
a. Acetylcholine
b. Serotonin
c. Norepinephrine
d. Dopamine
a. somatic nervous system
b. parasympathetic nervous system
c. sympathetic nervous system
d. Both b & c
a. forebrain
b. midbrain
c. hindbrain
d. sidebrain
a. are mirror images of each other that cannot be superimposed on one another
b. are differentiated by the direction in which they rotate plane-polarized light
c. can have different effects on an organism
d. all of the above
a. The type of response monitored could result in different dose-response functions for the same drug.
b. Larger doses of a drug necessarily result in an increased response.
c. The dose of a drug and the species to which the drug is administered both affect the effect of the drug.
d. Two of the above.
a. reduction
b. cleavage
c. oxidation
d. conjugation
a. neurohormone
b. neuromodulator
c. neurotransmitter
d. neuroenzyme
a. Inhibiting the reuptake of a neurotransmitter.
b. Activating presynaptic receptors or autoreceptors.
c. Binding to but not activating the receptors on the postsynaptic membrane of a target neuron.
d. All of the above.
a. Competitive Antagonism
b. Non-Competitive Antagonism
c. Physiological Antagonism
d. Pharmacological Antagonism
a. The relative refractory period
b. The absolute refractory period
c. the threshold
d. the resting potential
a. lipid soluble
b. very small in size
c. not bound (free)
d. all of the above
a. Terminal Buttons
b. Dendrites
c. Myelin Sheath
d. Axon Hillock
a. Terminal Buttons
b. Dendrites
c. Myelin Sheath
d. Axon Hillock
a. gall bladder
b. small intestine
c. kidney
d. liver
a. decrease in heart rate
b. decrease in mobility of the digestive system
c. increase in pupil size
d. increase in diameter of airways in the lungs
a. intraperitoneal
b. intravenous
c. intramuscular
d. per os
a. protects brain from xenobiotic substances
b. uniformity in depth around entire brain
c. only free drugs can get across the barrier
d. both a & c
a. mitochondria
b. amino acids
c. myelin sheaths
d. basal ganglia
a. the dose of the drug
b. the pKa
c. the local pH
d. all of the above
a. The most rapid method is intramuscular administration
b. Oral absorption is not affected by lipid solubility.
c. I.V. administration requires an aequeous vehicle.
d. None of the above
a. is surrounded by glial cells.
b. allows all drug molecules to pass freely into the tissues.
c. allows certain substances to "piggy back" across.
d. Both a & c.
a. is negative compared to the outside.
b. has a membrane potential of -30mV.
c. contains only sodium ions.
d. is maintained at the threshold level.
a. is a precursor to tyrosine.
b. is a catecholamine.
c. can cross the Blood Brain Barrier.
d. Both b & c.
a. adaption
b. tachyphylaxis
c. limited tolerance
d. immunostasis
a. is not affected by the environment.
b. involves habituation.
c. is to develop tolerance in one context but lose the tolerance in another context.
d. Both b & c.
a. A decrease in membrane potential.
b. The inside of the cell becomes more positive.
c. It results from an influx of Cl ions.
d. It results from a synaptic stimulation.
a. excretion
b. metabolism
c. absorption
d. distribution
a. pinocytosis
b. passive diffusion
c. carrier mediated diffusion
d. both b & c
a. intraperitoreal injection
b. intrathecal injection
c. transpleural injection
d. intracranial injection
a. dopamein
b. adrenalin
c. serotonin
d. noradrenaline
a. smooth muscle
b. cardiac muscle
c. skeletal muscle
d. glands
a. Agonist
b. Inverse Antagonist
c. Antagonist
d. Inverse Agonist
a. Concentration of the drug at its site
b. Rate of Accumulation at the Site
c. Dose of the Drug
d. All of the Above
a. involves attraction of similarily charged ions
b. involves repulsion of oppositely charged ions
c. involves attraction of oppositely charged ions
d. none of the above
a. effect properties of membrane itself
b. altering structure or function of sodium channels located in axonal membranes
c. alter balance of ions on two sides of the membrane
d. all of the above
a. men
b. women
c. Equal amounts for men and women
d.
a. concentration of drug
b. dose of drug
c. pH and PKA of drug
d. all of the above
a. Diencephalon
b. telencephalon
c. metencephalon
d. Both a&b
a. cocaine
b. heroin
c. LSD
d. marijuana
a. non-food substance
b. alters one or more biological processes
c. is an endogenous substance
d. has many historical connections
a. It has some currently accepted medical use
b. It is a Schedule 1 drug
c. Has a low abuse potential
d. All of the above
a. Psychostimulants
b. Major Tranquilizer
c. Sedative-hypnotics
d. Analgesics
a. Ionization
b. pH
c. Digestive Secretions
d. All of the above
a. Is the rate of drug metabolism directly proportional to the concentration of the drug.
b. Is independent of concentration.
c. Is the rate of drug metabolism for alcohol.
d.
a. Reduction
b. Cleavage
c. Oxidation
d. Diffusion
a. Intrathecal injection
b. Inhalation
c. Transdermal
d. All of the above
a. red b lood cells
b. adipose tissue
c. capillary endothelial cells
d. none of the above
a. is a weak acid
b. has a high pH
c. is ionized in the stomach
d. both a & b
a. absolute refractory period
b. relative refractory period
c. depolarization
d. hyperpolarization
a. influx of Na+
b. eflux of Cl-
c. influx of K+
d. all of the above
a. dopamine
b. serotonin
c. acetylcholine
d. epinephrine
a. Dopamine
b. Ach
c. NE
d. epinephrine
a. p.o.
b. i.p.
c. i.v.
d. all the same
a. Axon Hillock
b. Myelin Sheath
c. Dendrites
d. Both a & c
a. electrostatic pressure
b. gravitational force
c. osmotic pressure
d. both a & c
a. E, L-DOPA, NE
b. L-DOPA, NE, E
c. NE, L-DOPA, E
d. none of the above
a. Norepinephrine
b. Serotonin
c. Dopamine
d. Both a & c
a. very small
b. lipid-soluble
c. compatible with one of the carrier-mediated or active transport systems developed in the capillary and astrocyte cells
d. all of the above
a. the myelin sheath
b. the blood-brain barrier
c. the cerebral cortex
d. none of the above
a. Pavlov
b. Charvel
c. Freud
d. Leary
a. chlorpromazine
b. Prozac
c. lysergic diethylamide
d. clozapine
a. so-called "mind-expanding drugs"
b. ligands
c. psychadelic drugs
d. both a & c
a. exhibit first-order kinetics.
b. exhibit zero-order kinetics.
c. include ethanol.
d. both b & c
a. cocaine
b. alcohol
c. nasal spray
d. none of the above
a. Active Transport
b. Ionization
c. Diffusion
d. Spiked
a. Li ver
b. Kidney
c. Large intestines
d. Pancreas
a. numeriacal value of the threshold
b. indicates how safe a drug is
c. Rate of Tolerance
d. Rate of Activation in post synaptic cleft
a. Thorozine
b. Chlorpromazine
c. Prozac
d. Both a & b
a. 15
b. 80
c. 100
d. 90
a. aldehyde dehydrogenase
b. disulfiram
c. alcohol dehydrogenase
d. none of the above
a. skin rash
b. vertigo
c. menstrual irregularities
d. all of the above
a. caffeine
b. nicotine
c. amphetamine
d. alcohol
a. MDA
b. LSD
c. marijuana
d. PCP
a. first order kinetics
b. zero order kinetics
c. a and c
d. does not undergo kinetics
a. detrimental effect on vision
b. decreased sensitivity to taste, smell, and pain
c. increased reaction time
d. a and b
a. alcoholism
b. fetal alcohol syndrome
c. intoxication
d. none of the above
a. Librium
b. Tranxene
c. Xanax
d. Ativan
a. high therapeutic index
b. low therapeutic index
c.
d.
a. amphetamines
b. antipsychotics
c. sedative-hypnotics
d. benzodiazepines
a. barbiturates
b. amphetamines
c. anixiolytics
d. antipsychotics
a. has similar effects as amphetamines
b. can cause very strong physical dependence
c. can initiate panic attacks and seizures
d. all of the above
a. Mu- pain modulation
b. Delta - emotion modulation
c. Lambda- pleasure modulation
d. Kappa - possible sedating mediator
a. cocaine
b. amphetamines
c. opium
d. marijuana
a. alcohol-like intoxication
b. global paranoia
c. hebephrenia
d. a and c
a. they are just as effective, but cost less
b. they have about the same side effects, but cost less
c. they are significantly more effective and less toxic
d. none of the above
a. cocaine
b. caffeine
c. alcohol
d. LSD
a. medulla
b. basal ganglia
c. hypothalamus
d. substantia nigra
a. acne
b. increase in high-density lipoproteins (good cholesterol)
c. atrophied testicles
d. hypertension
a. acne
b. increase in high-density lipoproteins (good cholesterol)
c. atrophied testicles
d. hypertension
a. altered state of consciousness
b. inhibition of aggression and violence
c. euphoria
d. all of the above
a. altered state of consciousness
b. inhibition of aggression and violence
c. euphoria
d. all of the above
a. depression
b. alcoholism
c. arachnophobia
d. PMS
a. 40%
b. 60%
c. 80%
d. 160%
a. 40%
b. 60%
c. 80%
d. 160%
a. 40%
b. 60%
c. 80%
d. 160%
a. drink more
b. eat less
c. have higher amount of fat
d. don't play football to burn it off
a. drink more
b. eat less
c. have higher amount of fat
d. don't play football to burn it off
a. USA
b. Geece
c. France
d. Italy
a. .05
b. .1
c. .5
d. 1.0
a. sedative, hypnotic
b. hypnotic, sedative
c. stupid, healthy
d. depressive, stimulant
a. to escape or to cope
b. for curiosity or peer pressure
c. self-discovery or spiritual purpose
d. all of the above
a. to escape or to cope
b. for curiosity or peer pressure
c. self-discovery or spiritual purpose
d. all of the above
a. fear of withdrawl
b. physical reward
c. psychological reward
d. all of the above
a. Rapid mood swings
b. Extreme aggressiveness
c. Attention and effort for tasks is decreased
d. All of the above
a. ADD
b. Childhood Sz
c. Infantile autism
d. Mental retardation
a. Amphetamines
b. Lithium
c. Prozac
d. Tricyclics
a. Lack of interest in things
b. Have dilusions
c. Do not make friends
d. Both a & c
a. Amphetamines
b. Cocaine
c. Caffeine
d. Nicotine
a. Caffine
b. Amphetamines
c. Cocaine
d. LSD
a. sedation
b. delerium tremens
c. none of the above
d. both a and b
a. alcholic hepatitis
b. esophageal varices
c. cognitive and motor deficits
d. all of the above
a. 5
b. 10
c. 15
d. 20
a. Heroin
b. Marijuana
c. Lysergic acid diethylamide (LSD)
d. Methadone (Dolophine)
a. Cocaine
b. Morphine
c. Meperidine (Demerol)
d. Heroin
a. Methylphenidate
b. Amphetamine
c. Mescaline
d. Cocaine
a. Brewed coffee
b. Cocoa
c. Chocolate milk
d. Decaffeinated coffee
a. Competitive antagonism
b. Non-competitive antagonism
c. Pharmocological Antagonism
d. Physiological Antagonism
a. rate of absorption is more variable
b. may cause nausea and vomiting
c. rate of absorption slow
d. none of the above
a. clot formation
b. vessel irritation
c. allergic reaction
d. slower onset than transdermal administration
a. intravenous (IV)
b. per os (PO)
c. intra-arterial
d. intramuscular (IM)
a. a geriatric patient
b. an adolescent
c. an normal adult male
d. none of the above
a. Cleavage
b. Conjugation
c. Oxidation
d. Reduction
a. other drugs in the system
b. age
c. species
d. all of the above
a. dendrite
b. axon
c. myelin sheath
d. vesicle
a. Dopamine
b. Epinephrine
c. Norepinephrine
d. Serotonin
a. Pain perception
b. Stress reaction
c. primary reward
d. All of the above
a. Heart rate
b. Blood pressure
c. Respirations
d. all of the above
a. feeding
b. flight response
c. fight response
d. all of the above
a. lethargy
b. nonhealing ulcers
c. high blood pressure
d. brain damage
a. true
b. false
c.
d.
a. cardiac irregularities
b. moderate mental retardation
c. unusually small fingers and toes
d. small head circumference
a. true
b. false
c.
d.
a. headaches
b. asthma
c. sore throats
d. anxiety
a. true
b. false
c.
d.
a. marijuana
b. barbituates
c. amphetamines
d. ethanol
a. marijuana
b. barbituates
c. amphetamines
d. ethanol
a. first order
b. zero order
c. no order
d. none of the above
a. vomitting
b. passing out
c. walking around
d. two of the above
a. acetaldehyde
b. serotonin
c. epinephrene
d. dopamine
a. mental retardation
b. cleft palate
c. lung abnormalities
d. cardiac irregularities
a. inverse antagonist
b. inverse agonist
c. indirect agonist
d. antagonist
a. true
b. false
c.
d.
a. inhibit reuptake of catecholamines
b. mildly inhibit MAO
c. lower dopamine activity
d. two of the above
a. facilitating dopamine activity
b. facilitating norepinephrine activity
c. facilitating serotonin activity
d. none of the above
a. thyroid gland
b. pineal gland
c. pituitary gland
d. none of the above
a. herion
b. morphine
c. codeine
d. none are natural opiates
a. agonists
b. antagonists
c.
d.
a. dieting
b. increasing appetite
c. decreasing sleep
d. all of the above
a. (LSD)visual :(Sz) auditory
b. plesant: threatening/unpleasant
c. superimposed enviroment: distortion of exsisting enviornment
d. all of the above
a. decrease pupil size
b. increase blood pressure
c. increase heart rate
d. b&c
a. decrease pupil size
b. increase blood pressure
c. increase heart rate
d. b&c
a. schizophrenia , parkinsons
b. parkinsons, schizoprenia
c. schizophrenia , epilepsy
d. none of the above
a. give him coffee
b. lock him in a safe padded room
c. talk him down
d. give him something to eat
a. heroin
b. LSD
c. morphine
d. cocaine
QUESTIONS FROM D&B, FALL '98
a. Glycine
b. Peptides
c. Glutamate
d. GABA
a. stomach
b. G.I.
c. liver
d. All of these
a. eflux of Na+
b. eflux of Cl-
c. Influx of K+
d. Influx of Cl-
a. 50% of the drug is excreted
b. 100% of the drug is ionized
c. 50% of the drug is absorbed
d. 50% of the drug is ionized
a. BBB is not uniform throughout the brain
b. BBB is made up primarily of Astrocytes
c. BBB is surrounded by glial cells
d. Bound drugs are less likely than free drugs to penetrate the BBB
a. COMT and MAO
b. alpha 1 and alpha 2
c. muscarinic and nicotinic
d. alpha 1 and beta 1
a. Na+
b. Cl-
c. Ca++
d. K+
a. phosphodiesterase
b. acetic acid
c. protein kinase
d. adenylate cyclase
a. cleavage
b. oxidation
c. conjugation
d. phosphoralation
a. The point at which 50% of the drug has been metabolized
b. The amount of the drug needed in order to replace an endogenous chemical at that site
c. The point of maximum effect of the drug with the minimal side effects.
d. The dose of the drug that is effective in 50% of the subjects tested.
a. therapeutic window
b. plasma half-lives
c. lethal dose 50
d. effective dose 50
a. 7
b. 10
c. 3
d. 6
a. intravenously
b. by drug inhalation
c. subcutaneously
d. per os
a. homeostatic pressure / concentration gradient
b. concentration gradient / electrostatic pressure
c. electrostatic pressure / extracellular fluid
d. extracellular fluid / homeostatic pressure
a. thalmus
b. medulla
c. cerebellum
d. pons
a. Molecular Structure - Activity Classification
b. Drug Use Classification
c. Neurotransmitter Classification
d. Schedule Controlled Drug Classification
a. amines
b. amino acids
c. peptides
d. all of the above
a. The midbrain.
b. The cerebellum.
c. The reticular activating system.
d. The limbic system.
a. Estabish what the dose-response functions for the drugs are seperately.
b. Establish what the minimally effective doses of the two drugs are.
c. Determine whether the combonation of these two drugs results in an effect greater than that achieved by simply doubling the minimally effective dose of one of the drugs.
d. All of the above.
a. competitive antagonist
b. noncompetitive antagonist
c. physiological antagonist
d. synergism
a. when an individual overresponds to a drug
b. when an individual underresponds to a drug
c. when there is an unexpected response or unusual effect of a drug
d. both a and c
a. concentration and route of administration
b. concentration and rate of accumulation at the site of action
c. route of administration and rate of accumulation at the site of action
d. route of administration and the PKa of the drug
a. rapid onset of drug action
b. intense effects
c. vessel irritation and/or collapse
d. fine adjustments in drug dosage
a. median effective index
b. therapeutic index
c. Range of tolerance
d. none of the above
a. Cleavage
b. Oxidation
c. Reduction
d. Conjugation
a. K leakage
b. Overabundace of Cl
c. Overabundance of Na
d. Na leakage
a. Dopamine
b. Tyrosine
c. Epinephrine
d. All are precursors
a. Endorphins
b. Indoleamines
c. Catecholamines
d. Amino Acids
a. Lipid solubility
b. Drug concentration
c. Rate of blood flow
d. All are factors involved in per os absorbtion
a. "Affinity"
b. "Toxicity"
c. "Intrinsic Activity"
d. "Efficacy"
a. "Precursors"
b. "Autoreceptors"
c. "Ligands"
d. "Enzymes"
a. "Depolarization"
b. "Hyperpolarization"
c. "Superpolarization"
d. "Neuropolarization"
a. "Epi"
b. "NE"
c. "Ach"
d. "5-HT"
a. "Chemical name"
b. "Brand name"
c. "Generic name"
d. "Code name"
a. Occurs in response to repeated drug administration
b. Loss of effect relative to initial impact
c. Results in lesser amounts of drug being required to reinstate that initial effect
d. Results in greater amounts of drug being required to reinstate that initial effect
a. Task-drug association
b. Task-specific but generalizability
c. No development of tolerance without consequences
d. All of the above
a. genetics
b. sociological
c. both a and b
d. none of the above
a. axon hillock
b. cell body
c. terminal buttons
d. myelin sheath
a. clot formation
b. vessel irritation/ collapse
c. allergic reaction
d. all of the above
a. dose
b. duration
c. set
d. none of the above
a. CLEAVAGE
b. OXIDATION
c. CONJUGATION
d. ALL OF THE ABOVE
a. MOBILITY OF THE DIGESTIVE SYSTEM
b. DIAMETER OF AIRWAY IN THE LUNGS
c. DIAMETER OF BLOOD VESSELS IN THE DIGESTIVE SYSTEM
d. BOTH A AND C
a. LD100/ED50
b. ED100/LD50
c. ED50/LD50
d. ED1000/LD20
a. CHLOROPROMAZINE
b. HALPERIDOL
c. THORIDAZINE
d. AMITRIPTYLINE
a. Lipid solubility.
b. Active Secretion vs. Passive Diffusion.
c. pH.
d. All of the above.
a. Teratogenic effects.
b. A greater proportion of blood flow is distributed to an adult brain compared to a fetus or neonate.
c. Placenta is less permeable.
d. BBB is less developed.
a. (Tyrosine)-(Dopamine)-(L-Dopa)-(Norepinephrine)-(Epinephrine)
b. (Tyrosine)-(L-Dopa)-(Dopamine)-(Norepinephrine)-(Epinephrine)
c. (Tyrosine)-(Dopamine)-(L-Dopa)-(Epinephrine)-(Norepinephrine)
d. (Tyrosine)-(L-Dopa)-(Dopamine)-(Epinephrine)-(Norepinephrine)
a. functions that involve flight
b. hormone production and release
c. vegetative functions
d. insulin secretion
a. True
b. False
c.
d.
a. is found in various parts of the PNS
b. is not found in the CNS
c. has excitatory properties in the PNS
d. both a & c
a. toxicity
b. theraputic index
c. efficacy
d. threshold dose
a. I.V.
b. I.M.
c. P.O.
d. none of the above
a. the heart
b. the kidney
c. the intestines
d. the liver
a. axon hillock
b. soma passage
c. astrocyte
d. C.N.S
a. withdrawal
b. plasma half-lives
c. theraputic window
d. ED 1/2
a. inverse agonist
b. dose-response curve
c. drug graph
d. none of the above
a. Originates in the sacral region of the spinal cord and the medulla
b. Releases Norepinephrine at the target cells
c. Stimulation increases heart rate and blood pressure
d. None of the above are true
a. NOREPINEPHRINE
b. DOPAMINE
c. SEROTONIN
d. EPINEPHRINE
a. Benzodiazepines
b. Alcohol
c. Barbiturates
d.
a. Benzodiazepines
b. Alcohol
c. Barbiturates
d. All from the above
a. 0.1%
b. 0.01%
c. 1.0%
d. 0.001%
a. 6%
b. 10%
c. 5%
d. 20%
a. Early stage of fat and this causes one to have fatty liver.
b. Deatory liver cells (cirrhosis).
c. Change the rate of metabolism in the liver.
d. All from the above.
a. Inhibit excitalory of effects of glutamate.
b. Asparate at NMDA receptors-ion complex.
c. Lesser calcium and sodium ion to the neurons and decrease depolize.
d. All from the above.
a. Vomiting
b. Passout
c. Stuporous
d. All from the above
a. 2
b. 1
c. 6
d. 7
a. 2
b. 100
c. 30
d. 90
a. Oxidize fats, this cause to form complex fat.
b. reduces the rate of liver produce glucose.
c. blood sugar level depressed.
d. all from the above.
a. Low dose will have psychological calming effect.
b. High dose will have hypnotic or sleep-inducing.
c. Twp from the above .
d. None from the above.
a. conflicting goals
b. over-supply of treatment
c. poor follow through
d. process evaluation (assess methods)
a. alcohol
b. amphetamines
c. canabinoids
d. they are all lipid soluble
a. hallucinations
b. apathy
c. dellusions
d.
a. to get to sleep
b. to lose weight
c. to manipulate their mood
d. because of a high self-esteem psychological profile
a. psychological
b. physiological
c. both
d. neither
a. ANTI-DEPRESSANT
b. SEDATIVE-HYPNOTIC
c. HYPERVENTILATOR
d. NONE OF THE ABOVE
a. SOCIAL ASSERTIVENESS
b. AGGRESSION
c. ENHANCEMENT OF SEXUAL PERFORMANCE
d. ALL OF THE ABOVE
a. ALCOHOL ABSOLUTE VALUE
b. LETHALITY
c. ALCOHOLISM
d. PROOF
a. 15
b. 100
c. 40
d. 60
a. DELIRIUM TANTRUMS
b. ALCOHOLISM
c. AMNESIA
d. BLOOD ALCOHOL CONTENT
a. ARACHNAPHOBIA
b. PANIC ATTACK
c. BOTH A & B
d. AGORPHOBIA
a. COCAINE
b. HEROIN
c. NICOTINE
d. CAFFEINE
a. ASTHMA
b. THE FLU
c. PNEUMONIA
d. ALCOHOLISM
a. HEROIN
b. LSD
c. COCAINE
d. EXTASY
a. NARCOTIC
b. AGONIST
c. OPIOIDS
d. TWO OF THE ABOVE
a. MAKING PEOPLE HAPPY
b. INDUCING SLEEP
c. REDUCING PAIN
d. ALL OF THE ABOVE
a. HALLUCINATIONS
b. DELUSIONS
c. ILLUSIONS
d. NONE OF THE ABOVE
a. IBOGAINE
b. HALLUCINOGEN
c. PSYCHEDELIC
d. NONE OF THE ABOVE
a. METHYL
b. ETHONOL
c. PROTONOL
d. NONE OF THE ABOVE
a. 2-3 HOURS
b. 1 DAY
c. IT NEVER DOES GET ABSORBED
d. 30 -60 MINUTES
a. PSYCHOLOGICAL
b. PHYSILOGICAL
c. NON-EXISTANT
d. TWO OF THE ABOVE
a. ACETYCHOLNE
b. NOREPINEPHRINE
c. EPINEPHRINE
d. SEROTONIN
a. BEING SICK AND BEING HEALTHY
b. MANIA AND DEPRESSION
c. BOTH A & C
d. NONE OF THE ABOVE
a. TRIANGLE ANTI-DEPRESSANT
b. TRIPLE ANTI-DEPRESSANT
c. TRICYCLICS
d. TWO OF THE ABOVE
a. HYSTEROID DYPHORIA
b. MONOMINE OXIDASE
c. HYPERTENSIVE CRISIS
d. NONRESPONDING ATYPICAL DEPRESSION
a. MARIJUANA
b. HEROIN
c. ALCOHOL
d. LSD
a. LITHIUM
b. TRAZODONE
c. BUSPINONE
d. NONE OF THE ABOVE
a. 20
b. 50
c. 2
d. 10
a. FAILURE TO DEVELOP INTERPERSONAL RELATIONSHIPS
b. BIZARRE MOTOR DEVELOPMENT
c. DESIRE FOR SAMENESS IN SURROUNDINGS
d. ALL OF THE ABOVE
a. TOURETTE'S SYNDROME
b. ADD
c. EPLIPSY
d. NONE OF THE ABOVE
a. TOURETTE'S SYNDROME
b. ADD
c. EPLIPSY
d. NONE OF THE ABOVE
a. ACETYCHOLINE
b. NOREPINEPHRINE
c. EPINEPHRINE
d. SEROTONIN
a. CNS ATROPHY
b. RENAL DAMAGE
c. INSUFFICIENT OXYGEN
d. ALL OF THE ABOVE
a. THE INDIVIDUAL
b. HOW MUCH COCA-COLA YOU DRINK
c. THR DOSE
d. TWO OF THE ABOVE
a. Hatian
b. African
c. Chinese
d. all of the above
a. 1-5
b. 5-7
c. 7-10
d. 20 or more
a. Decrease in BP
b. Increase in HR
c. Increase in body tempature
d. Increase in muscular tension
a. ADD
b. Retardation
c. Schizophrenia
d. all of the above
a. occurs several weeks after LSD injection
b. premormid state
c. explanations are hampered by confounds
d. all of the above
a. heroin
b. cocaine
c. marijuana
d. none of the above
a. violence
b. ESP
c. easily distracted
d. temporal disintegration
a. alcoholics
b. stunt doubles
c. burn victims
d. college students studying for finals
a. short plasma half life
b. long plasma half life
c. active metabolites
d. none of the above
a. endorphin hypothesis
b. oxidation hypothesis
c. dopamine hypothesis
d. both a & c
a. 2
b. 2
c. 5
d. 12+
a. 0% improvement
b. 25% improvement
c. 50% improvement
d. 70% improvement
a. frequent hot and cold spells
b. weight gain
c. dystonia
d. both b&c
a. age
b. culture
c. gender
d. late onset
a. guilt
b. elevated positive mood
c. insomnia
d. both a & c
a. antipsychotics
b. prozac
c. antidepressants
d. both a & c
a. parnate
b. advil
c. nardil
d. both a & c
a. enkephalins, dynorphins, pemoline magnesium
b. enkephalins, maagnesium, triptomine
c. enkephalins, H2O, hemoglobin
d. none of the above
a. Mu
b. Beta
c. Delta
d. Kappa
a. decreased sex drive
b. constipation
c. poor nutrition
d. all of the above
a. psychological dependence
b. FLU
c. Migraines
d. none of the above
a. little evidence for excessive amounts
b. requires a much higher dose than usual
c. rapidity of death consistent with narcotic
d. both a & b
a. 95% of depressed people
b. 70% of depressed people
c. 20% of depressed people
d. none of the above
a. alzheimers
b. parkinson
c. ADHD
d. depression
a. amphetamines
b. cannabinoids
c. LSD
d. antipsychotics
a. decrease in serotonin
b. increase in dopamine
c. decrease in norepinephrine
d. decrease in MAOI
a. narcilepsy
b. ADHD
c. both a and b
d. none
a. onset of action
b. side effects
c. toxicity
d. these are all important
a. tricyclics
b. MAOIs
c. anxiolytics
d. SSRIs
a. ADHD
b. Gilles de Tourettes
c. Autism
d. none of the above
a. illusions
b. hallucinations
c. delusions
d. none of the above
a. 50-60 hours
b. 10-12 hours
c. 30-60 minutes
d. 5-10 hours
a. LSD
b. Psilocin
c. Mescaline
d. DMT
a. 1 to 2 weeks
b. for life
c. 2 to 3 years
d. 4 to 6 months
a. Sedative hypnotics
b. Lithium
c. antipsychotics
d. Fenfluramine
a. <75
b. <90
c. <105
d. 80< x <100
a. no fear of danger
b. tendency to spin objects
c. inappropriate laughing
d. all of the above
a. excess of dopaminergic neurons in the basal ganglia
b. destruction of dopaminergic neurons in the basal ganglia
c. excess of serotonin receptors
d. lack of serotonin receptors
a. slow movements
b. muscular rigidity
c. tremors
d. all of the above
a. L-DOPA can't cross the BBB
b. dopamine can't cross the BBB
c. dopamine cannot be isolated
d. L-DOPA is more cost effective
a. Cocaine
b. LSD
c. marijuana
d. heroin
a. increase in blood pressure
b. increase in heart rate
c. decrease in body temperature
d. bronchial dilation
a. women
b. smokers
c. both a and b
d. none of the above
a. zero
b. first
c. second
d. third
a. highly water soluble
b. not fat soluble
c. able to pass the blood brain barrier
d. all of the above
a. 50
b. 10
c. 90
d. 25
a. .5%
b. .15%
c. 1%
d. .33333%
a. Benzodiazapine
b. Barbiturates
c. Anxiolytics
d. none of the above
a. USA
b. England
c. France
d. Ireland
a. alcohol oxidase
b. alcohol metabolase
c. alcohol formulase
d. alcohol dehydrogenase
a. Ethanol -> Acetyl Coenzyme A -> Acetaldehyde
b. Ethanol -> Acetaldehyde -> Acetyl Coenzyme A
c. Acetyl Coenzyme A -> Ethanol -> Acetaldehyde
d. Acetaldehyde -> Acetyl Coenzyme A -> Ethanol
a. the percentage of ethanol
b. one-half the percentage of ethanol
c. double the percentage of ethanol
d. four times the perentage of ethanol
a. dependence
b. addiction
c. tachysphlaxis
d. excretion
a. vomiting
b. passing out
c. both a & b
d. none of the above
a. prevent lethal effect
b. block hyperpolarization
c. prevent behavioral effects
d. none of the above
a. build-up of acetylaldehyde
b. build-up of Acetyl Coenzyme A
c. build-up of Acetaldehyde
d. inability to metabolize alcohol in the liver
a. dilation of pupils
b. increase in blood pressure
c. increase in heart rate
d. all of the above
a. more likely in males
b. discovered in 1943
c. has an incidence rate of 1/100,000
d. symptoms are generally noticeable in the first 30 months
a. belladona alkaloid
b. ketalar
c. amphetamine
d. caffeine
a. 5%
b. 2%
c. 0.5%
d. 8%
a. succeptibility to viral infection
b. deterioration of the blood brain barrier
c. agranulocytosis
d. both a & c
a. 2-3 hours
b. 2-3 days
c. 2-3 weeks
d. 2-3 months
a. Nucleus Accumbens
b. Ventral Tegmental Area
c. Medial Preoptic Area
d. all of the above
a. potassium
b. sodium
c. chlorine
d. ammonium
a. caffeine
b. a cold shower
c. time
d. more alcohol
a. Lithium
b. LSD
c. L-dopa
d. naltrexone
a. Lithium
b. LSD
c. L-dopa
d. naltrexone
a. sedative-hypnotics
b. anxiolytics
c. anticonvulsants
d. none of the above
a. tremors
b. slowness of movement
c. myscular rigidity
d. high blood pressure
a. can cross BBB
b. cannot cross BBB
c. effective in 80% of Parkinson's disease patients
d. precursor to dopamine
a. periods of blank stares
b. loss of consciousness
c. rapid eye blinking
d. twitching movements
a. bromocriptine
b. selegiline
c. anticholinergics
d. none of the above
a. fingers
b. head
c. limbs
d. two of the above
a. grunts
b. words/phrases
c. sounds
d. all of the above
a. OCD
b. autism
c. schizophrenia
d. none of the above
a. reduction in GABA levels
b. head injury
c. stroke
d. allergies
a. a natural high
b. a tipoff that something is about to happen
c. postseizure amnesia
d. an allergy
a. clonazepam
b. phenytoin
c. primidine
d. carbamazepine
a. Alzheimer's
b. Parkinson's
c. schizophrenia
d. depression
a. 1/5
b. 1/3
c. 1/4
d. 1
a. increased body fat
b. decreased body fat
c. increased plasma protiens
d. two of the above
a. caffeine
b. MAO inhibitors
c. ritalin
d. none of the above
a. Hyperactivity
b. MInimal Brain Dysfunction
c. Hyperkinetic Syndrome
d. all of the above
a. over arousal
b. extreme aggressiveness
c. little evidence of fear
d. rapid mood swings
a. Sedative hypnotics
b. antipsychotics
c. stimulants
d. none of the above
a. Depression
b. Autism
c. Schizophrenia
d. Bipolar disorder
a. Depression
b. Autism
c. Schizophrenia
d. Bipolar disorder
a. weight loss
b. decrease in sex drive
c. uncontrollable salivation
d. incontinence
a. 400
b. 40
c. 4
d. 4000
a. imipramine
b. prozac
c. L-DOPA
d. Xanax
a. Mild to moderate mental retardation
b. large head circumference
c. cardiac irregularities
d. hyperactive behavior as a child
a. heroin
b. morphine
c. cocaine
d. both a & b
a. sedative-hypnotic/analgesic properties
b. acts stereospecifically on endorphin/enkephalin receptors
c. antagonized by Narcan
d. all are criteria
a.
b.
c.
d.
a. mu
b. alpha
c. delta
d. kappa
a. Clonidine
b. Buprenex
c. ion trapping
d. Methadone Maintenance
a. dry mouth
b. decreased sweating
c. glaucoma, decreased pressure within the eyeball
d. all of the above
a. no behavioral effects
b. first-order kinetics
c. no tolerance
d. zero-order kinetics
a. fat soluble
b. highly water soluble
c. readily crosses BBB
d. both b & c
a. is the interaction of yeast and sugar in grains (beer)
b. is the interaction of yeast and sugar in fruits (wine)
c. a purification process for water only
d. none of the above
a. is the interaction of yeast and sugar in grains (beer)
b. is the interaction of yeast and sugar in fruits (wine)
c. a purification process for water only
d. none of the above
a. fat soluble
b. highly water soluble
c. readily crosses the BBB
d. both b& c
a. abstract reasoning ability
b. inability to shift cognitive and attentional sets
c. cerebral atrophy and organ atrophy
d. allo of the above
a. improved memory capacity
b. Korsakoff's Syndrome
c. improved perceptual, visual, and psychomotor ability
d. all of the above
a. acetyl coenzyme A preceeds acetaldehyde
b. alcohol dehydrogenase is in the small intestine
c. aldehyde dehydrogenase breaks down acetaldehyde into acetyl coenzyme A
d. carbon dioxide is not pat of the citric acid cycle
a. results in increased urination
b. is characterized by cellular death and organ inflammation
c. is a lung disease
d. is characterized by yellowing of the skin and whites of the eyes
a. neuropathy
b. hypergonadism
c. estrogen stimulation
d. hypogonadism
a. is due to behavioral compensation
b. down regulation to GABA A
c. up regulation of NMDA
d. all of the above
a. occurs in amounts greater than 2 ounces
b. occurs in combination with another sedative hypnotic
c. are possibly due to alcohols ability to stimualte production of the enzyme t-PA
d. are due to RO15-4513 's hyperpolarizing effects
a. are minor tranquilizers because they have minor effects
b. action is blocked by Librium
c. has a low therapeutic index
d. receptors facilitate activity of GABA agionist
a. antagonism of central adenosine receptors results in increase firing rate
b. cortical neurons on the locus coerulus
c. may be mediated by NE
d. all of the above
a. tolerance does not develop
b. extroverts show dose dependent improvements in performance
c. introverts have no reaction
d. both b & c
a. amphetamine is contingent upon catecholamine reuptake inhibition
b. amphetamine is contingent on Na
c. cocaine is contingent on monoamine reuptake inhibition
d. both a & c
a. effects are snow lights and formication
b. gum relieves dependency
c. has sympathomimetic effects
d. decreases intracellular Ca levels
a. delta, sigma, theta
b. alpha, kappa, alpha
c. mu, delta, kappa
d. mu, theta, beta
a. pain, medulla, delta receptors
b. heroin, spinal cord, endorphins,
c. morphine, spinal cord, dynorphins
d. morphine, spinal cord, enkephalins
a. inhibit proteases
b. inhibit adenylate cyclase and c-AMP
c. inhibit NE
d. none of the above
a. receptors act through G-protein secondary messenger systems to inhibit adenylate cyclase and c-AMP
b. presynaptically inhibits Ca
c. postsynaptically hyperpolarizes the membrane
d. all of the above
a. continue using morphine at lower doses
b. continue using morphine at higher doses
c. switch to a drug with an affinity for delta receptors
d. switch to a drug with an affinity for mu receptors
a. methadone maintenance and LAAM
b. Buprenex
c. both a & b
d. none of the above
a. I am about to graduate from college
b. getting old
c. becomin abstinent without treatment
d. becoming abstinent from sex
a. share a basic similarity with DA, NE
b. are nonexistant
c. has no subjective effects
d. none of the above
a. evidence that DA antagonist improve Sz symptoms
b. DA agonist worsen Sz symptoms
c. increased levels of D2 receptors in the basal ganglia
d. all of the above
a. serotonin which may play an inhibitory role in DA activity and Epinephrine
b. serotonin which my play an excitatory role in DA activity and NE
c. serotonin which may play an inhibitory role in DA activity and NE
d. all of the above
a. educational lectures/films.
b. anxiety and stress management.
c. confrontational counseling.
d. individual psychotherapy.
a. heavy narcotic use.
b. Tourrette's Syndrome.
c. Fetal Alcohol Syndrome.
d. Attention Deficit Hyperactivity Disorder.
a. anxiety-related symptoms
b. anticonvulsants
c. sleep aids
d. all of the above
a. is impaired thinking such as difficultly understanding and using abstract concepts.
b. side effect of prolonged use of neuroleptic drugs.
c. type of brain damage caused by a thiamine defiency.
d. none of the above.
a. It acts sterospecifically on endorpin/enkephalin receptors.
b. It generally has sedative-hypnotic and analgesic properties.
c. It is any drug that is highly abusable and addicting.
d. Both a & b.
a. Methyphenidate
b. Lithium
c. Prozac
d. none of the above
a. Cocaine
b. Caffeine
c. Nicotine
d. none of the above
a. 2hrs
b. 6hrs
c. 5hrs
d. 1hr
a. Interference with short-term and long-term memory
b. Interference with classroom functioning
c. Acute panic anxiety reaction
d. all of the above
a. 5%
b. 9%
c. 1%
d. 2%
a. Cross-cultural studies
b. Gender
c. Age
d. All of the above
a. Heart
b. kidneys
c. liver
d. None of the above
a. one
b. zero
c. two
d. three
a. Complex cogntive skills
b. Fine learned (followed by gross learned) motor skills
c. Visual accomodation and conditioned reflexes
d. All of the above
a. hypogonadism
b. decreased libido
c. decreased testosterone
d. All of the above
a. 5%
b. 10%
c. 15%
d. 20%
a. cleft palate
b. small head circumference
c. mild to moderate mental retardation
d. none of the above
a. High
b. Low
c. Moderate
d. We do not know yet
a. Easily absorbed from Digestive System and reach brain quickly
b. Metabolized slowly and effects on sleep similar to Barbs
c. reaction time increases and and improves skills
d. both a and b
a. caffeine
b. alcohol
c. nicotene
d. marijuana
a. caffeine
b. alcohol
c. nicotene
d. marijuana
a. dose
b. frequency of behavior without the drug
c. the individual
d. all of the above
a. increase blood pressure
b. decrease heart rate
c. decrease body temperature and muscle tension
d. both a and b
a. prevents sleep
b. suppresses REM Sleep
c. Rx for Narcolepsy
d. all of the above
a. admit they are out of control
b. self-help groups
c. having pressure put on them to seek treatment when they don't want to go
d. both a and b
a. genetic factors
b. history of major depression and anxiety disorders
c. reinforcers
d. all of the above
a. pain modulation region
b. morphine/naloxone selective
c. euphorigenic properties/opioid withdrawal
d. all of the above
a. mu and alpha
b. alpha and delta
c. delta and kappa
d. both a and c
a. increased sex drive
b. respiratory depression
c. impotence
d. both a and c
a. lower birth rate
b. high birth rate
c. adequate bonding
d. none of the above
a. Monoamine-related substances, cannanbinoids, anticholinergics, and dissociative anesthetics
b. Monoamine-related substances, alcohol, anticholinergics, and dissociative anesthetics
c. Monoamine-related substances, cannanbinoids, anticholinergics, and narcotics
d. none of the above
a. distortions in body image
b. feelings of depersonalization
c. a sense of timelessness
d. all of the above
a. distortions in body image
b. feelings of depersonalization
c. a sense of timelessness
d. all of the above
a. anticholinergics
b. monoamines
c. cannabinoids
d. dissociative anesthestics
a. 1%
b. 2%
c. 3%
d. 4%
a. ~40% Improvement
b. ~50% Improvement
c. ~80% Improvement
d. ~70% Improvement
a. Enduring depressed mood
b. anhedonia
c. suicidal
d. all of the above
a. symptom-profile efficacy
b. onset of action
c. potential side-effect profile
d. all of the above
a. Tea/Coffee
b. Tobacco
c. Alcohol
d. Mushrooms
a. Pharmacodynamics
b. Antagonist
c. Ligand
d. Agonist
a. Phase III
b. Phase I
c. Phase IV
d. Phase II
a. Hypothalamus
b. Basal Ganglia
c. Amygdala
d. Raphe
a. Sensitization
b. Cross Tolerance
c. Habituation
d. Tachyphylaxis
a. psychotropic
b. psychoactive
c. both a and b
d. neither a nor b
a. Phase I
b. Phase II
c. Phase III
d. Phase IV
a. Intravenous injection
b. Rectal
c. Mucous membranes
d. Oral
a. tolerance to one drug resulting in tolerance to another drug
b. the ability to develop tolerance in one context but lose tolerance in another contex
c. the decrease in sensitivity to a drug over a very short period
d. none of the above
a. barbiturates
b. mescaline
c. cocaine
d. nasal spray
a. number of receptors necessary for general CNS functioning
b. postsynaptic receptors
c. receptors of a specific type that must be occupied before a response can begin to occur
d. form when a person is critically dependent on drugs
a. have an I.V. route of administration
b. pass through the G.I. tract
c. pass through membranes
d. have a large molecular structure
a. 85 billion neurons
b. 185 billion neurons
c. 85 million neurons
d. 150 billion neurons
a. amines
b. agonists
c. norephedrines
d. MAO inhibitors
a. activates the fight/flight response
b. increases heartrate
c. increases the mobility of the digestive system
d. increases the diameter of the blood vessels in the muscles
a. Capillaries
b. Oligodendrocytes
c. Astrocytes
d. Neurons
a. Intravenous injection
b. Oral
c. Intramuscular injection
d. Inhalation
a. neurotransmitter
b. hormone
c. neuron
d. both "a" and "b"
a. zero-order kinetics
b. first-order kinetics
c. third-order knietics
d. none of the above
a. basal frontal lobe
b. raphe
c. substantia nigra
d. locus cereolous
SUMMER 1999 (Part II)
a. Men have a higher fat to water ratio
b. Women have a higher fat to water ratio
c. Men metabolize and excrete alcohol quicker
d. Women absorb the alcohol from the stomach quicker
a. True
b. False
c. Need more information
d. Only in males
a. Tryptophan
b. GABA
c. Lysine
d. Tyrosine
a. neurotransmitter would be inhibited
b. neurotransmitter would not be inhibited at all
c. the person would die because of paralysis of his/her diaphragm
d. nothing would happen until an agonist came alone and knocked the antagonist out
a. L-Dopa
b. R-Dopa
c. LL-Dopa
d. None of the above
a. cocaine
b. Heroin
c. Acid
d. Something you make
a. Hullucinations
b. always wanting sexual telations
c. getting physically ill
d. none of the above
a. intense feelings of pleasure
b. violence
c. psychosis
d. all of the above
a. mushrooms
b. cocaine
c. alchohol
d. Heroin
a. "Ketamine"
b. "Anticholinergics"
c. "Sedative-Hypnotics"
d. "Cocaine"
a. "Females"
b. "males"
c. "Older people"
d. "Teenagers"
a. ".08%"
b. ".10%"
c. ".05%"
d. ".01%"
a. "Librium"
b. "Xanax"
c. "Alcohol"
d. "Serax"
a. "Alcohol"
b. "Caffeine"
c. "Cocaine"
d. "Heroin"
a. "Down-regulation of adenosine"
b. "Up-regulation of adenosine"
c. "both a and b"
d. "none of the above"
a. "strong base"
b. "weak base"
c. "ionized in stomach"
d. 'both b and c"
a. "Opioid receptors"
b. "Opiates"
c. "Amphetamines
d.
a. "Opioid receptors"
b. "Opiates"
c. "Amphetamines"
d. "both a and c"
a. "Decrease in sex drive"
b. "Respiratory depression"
c. "Constriction of pupil"
d. "All of the above"
a. "Cannabinoid"
b. "Marijuana"
c. "PCP"
d. "None of the above"
a. "5%"
b. "10%"
c. "20"
d. "2%"
a. fetal alcohol syndrome
b. most common childhood disorder for which medication is prescribed
c. hyperstimulation of the basal ganglia
d. a congential defect
a. exacerbates withdrawal syndrome from psychostimulants
b. increases the euphoric effects of abstinence syndrome
c. suppresses the "craving" in withdrawal from psychostimulants
d. is a local anesthetic - schedule 2
a. fear of abstinence syndrome
b. an alternate to primary dependence
c. secondary characteristics of drug addiction
d. the secondary drug of choice for an addict
a. marijuana
b. "pinpoint" pupils
c. narcolepsy
d. anticholinergics
a. is a CNS stimulant
b. blocks opioid receptors
c. is in the secondary messenger system
d. is produced by the autoreceptors
a. need much higher doses of medications for clinical efficacy
b. therapeutic index of drugs becomes irrelevant
c. need much smaller doses of medications for clinical efficacy
d. are likely to become addicted when self administering drugs
a. Dopamine antagonists improve Sz symptoms
b. Dopamine agonists worsen Sz
c. Elevated dopamine receptors found in Sz patients
d. Dopamine metabolites are not elevated in Sz patients
a. Schitzophrenia
b. ADD
c. Infantile Autism
d. Epilepsy
a. Schitzophrenia
b. ADD
c. Infantile Autism
d. Epilepsy
a. Parkinson's Disease
b. Alzheimer's Disease
c. Tourette's Syndrome
d. Depression
a. Nicotine
b. Alcohol
c. Caffeine
d. Marijuana
a. Mu Receptor
b. Sigma Receptor
c. Delta Receptor
d. Kappa Receptor
a. 1970
b. 1971
c. 1972
d. 1973
a. 1 out 1000
b. 1 out of 50
c. 1 out of 200
d. 1 out of 500
a. France
b. Italy
c. Portugal
d. United States
a. True
b. False
c.
d.
a. Down's Syndrome
b. Fragile X Syndrome
c. Fetal Alcohol Syndrome
d. Chromosomal Disorder Syndrome
a. "instantaneous diffusion across the membrane"
b. "difficult diffusion across the membrane"
c. "easier diffusion across the membrane"
d. "termination of diffusion of the membrane"
a. "local pH factor"
b. "fist-pass metabolism"
c. "GI content"
d. "slow absorption"
a. "Infantile autism"
b. "ADD"
c. "mental retardation"
d. Epilepsy"
a. "PCP"
b. "Cocaine"
c. "Marijuana"
d. "LSD"
a. "brain receptor"
b. "inhibits NT release"
c. "high lipid solubility"
d. "enhances Ach functioning"
a. "maximum efficacy"
b. oil/water partition coefficient"
c. "lipid-solubility"
d. plasma half-life
a. "salt form"
b. "particle size"
c. "vehicle"
d. "all the above"
a. "indirect agonist"
b. "intrinsic affinity"
c. "affinity"
d. "inverse agonist"
a. GABA
b. MU
c. Kappa
d. cannabinoid
a. true
b. false
c.
d.
a. true
b. false
c.
d.
a. true
b. false
c.
d.
a. true
b. false
c.
d.
a. "Tyrosine--L-Dopa--Dopamine--Norepinephrine--Epinephrine"
b. "L-Dopa--Dopamine--Tyrosine--Norepinephrine--Epinephrine"
c. "L-Dopa--Dopamine--Tyrosine--Epinephrine--Norepinephrine"
d. Tyrosine--L-Dopa--Dopamine--Epinephrine--Norepinephrine"
a. "increases the diameter of blood vessels in the muscle"
b. "increases the diameter of blood vessels in the digestive system"
c. "decreases diameter of airways in the lungs"
d. "increases mobility of the digestive system"
a. "Infantile autism"
b. "ADD"
c. "mental retardation"
d. "epilepsy"
a. "mimicker"
b. "inhibits NT release"
c. "high lipid solubility"
d. "enhances Ach functioning"